相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic significance of sphingosine kinase 2 expression in non-small cell lung cancer
Qiushi Wang et al.
TUMOR BIOLOGY (2014)
The nonlysosomal β-glucosidase GBA2 promotes endoplasmic reticulum stress and impairs tumorigenicity of human melanoma cells
Sonia-Caroline Sorli et al.
FASEB JOURNAL (2013)
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics
L. Y. Dimberg et al.
ONCOGENE (2013)
Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells
Kaamar Azijli et al.
JOURNAL OF CELL SCIENCE (2012)
TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies
Christian T. Hellwig et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Characterization of Isoenzyme-Selective Inhibitors of Human Sphingosine Kinases
Peng Gao et al.
PLOS ONE (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Targeting NFκB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2
James W. Antoon et al.
CANCER BIOLOGY & THERAPY (2011)
Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI3K/Akt/NF-κB Pathway in Human Non-Small Cell Lung Cancer
Libing Song et al.
CLINICAL CANCER RESEARCH (2011)
Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy
Christopher R. Gault et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
TRAIL receptor targeting therapies for non-small cell lung cancer: Current status and perspectives
J. H. Stegehuis et al.
DRUG RESISTANCE UPDATES (2010)
Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2
Kevin J. French et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
A Novel Sphingosine Kinase Inhibitor Induces Autophagy in Tumor Cells
Vladimir Beljanski et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Inhibition of proliferation and apoptosis induced by a Na+/H+ exchanger-1 (NHE-1) antisense gene on drug-resistant human small cell lung cancer cells
Shujun Li et al.
ONCOLOGY REPORTS (2009)
Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient Survival
Jun Li et al.
CLINICAL CANCER RESEARCH (2008)
Directing cancer cells to self-destruct with pro-apoptotic receptor agonists
Avi Ashkenazi
NATURE REVIEWS DRUG DISCOVERY (2008)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
The TRAIL apoptotic pathway in cancer onset, progression and therapy
Ricky W. Johnstone et al.
NATURE REVIEWS CANCER (2008)
TRAIL in cancer therapy:: present and future challenges
Delphine Merino et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
Klaus W. Wagner et al.
NATURE MEDICINE (2007)
Targeting death-inducing receptors in cancer therapy
K. Takeda et al.
ONCOGENE (2007)
Sphingolipids and cell signaling: Involvement in apoptosis and atherogenesis
O. M. Ipatova et al.
BIOCHEMISTRY-MOSCOW (2006)
Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models
D Pchejetski et al.
CANCER RESEARCH (2005)
Resistance to TRAIL is associated with defects in ceramide signaling that can be overcome by exogenous C6-ceramide without requiring down-regulation of cellular FLICE inhibitory protein
C Voelkel-Johnson et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue
KR Johnson et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2005)
Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis
ZY Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice
CH Hao et al.
CANCER RESEARCH (2004)
TRAIL and apoptosis induction by TNF-family death receptors
SL Wang et al.
ONCOGENE (2003)
Increased expression of Mcl-1 is responsible for the blockage of TRAIL-induced apoptosis mediated by EGF/ErbB1 signaling pathway
ES Henson et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Sphingosine-1-phosphate: An enigmatic signalling lipid
S Spiegel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Defining characteristics of Types I and II apoptotic cells in response to TRAIL
N Özören et al.
NEOPLASIA (2002)
Sphingosine 1-phosphate, a key cell signaling molecule.
S Spiegel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling
S Kreuz et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Ceramide glycosylation potentiates cellular multidrug resistance
YY Liu et al.
FASEB JOURNAL (2001)
Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform
H Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
